Date | Title | Description | Source |
30.10.2023 | Entrepreneur of the Year Award für Urban Connect und VectivB... |
Mit dem EY Entrepreneur Of The Year Award 2023 hat das Prüfungs- und Beratungsunternehmen EY in de... | startuptic... |
08.09.2023 | Startups und Scaleups im Finale des EY Entrepreneur Of The Y... |
Die unabhängige Jury hat entschieden, wer am 27. Oktober beim EY Entrepreneur Of The Year 2023 im ... | startuptic... |
23.05.2023 | Ironwood Pharma to acquire VectivBio for more than USD 1 bil... |
VectivBio is a clinical-stage biotechnology company focused on the discovery and development of tr... | startuptic... |
16.03.2023 | VectivBio and its partner conduct Japan-centric clinical tri... |
Based in Basel, VectivBio is a clinical-stage biopharmaceutical company pioneering novel transform... | startuptic... |
20.10.2022 | VectivBio raises $125 million |
VectivBio is focussed on therapies for severe rare conditions. Lead product candidate apraglutide ... | startuptic... |
13.10.2022 | VectivBio Announces Pricing of $125 Million Underwritten Off... | BASEL, Switzerland, Oct. 13, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VE... | forbion.co... |
13.10.2022 | VectivBio Announces Pricing of $125 Million Underwritten Off... | - | tcgcrossov... |
13.10.2022 | VectivBio Announces Pricing of $125 Million Underwritten Off... | - | orbimed.co... |
05.07.2022 | VectivBio Announces Closing of $54 Million Aggregate Financi... |
VectivBio is a global clinical-stage biotechnology company focused on transforming and improving t... | startuptic... |
29.06.2022 | VectivBio Announces Closing of $54 Million Aggregate Financi... | BASEL, Switzerland, June 29, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VE... | globenewsw... |
15.06.2022 | Forbion Growth Opportunities Fund II leads USD 50 million pl... | Amsterdam, The Netherlands, 15 June 2022 -- Forbion, a leading European life sciences venture capita... | forbion.co... |
14.06.2022 | VectivBio Announces Pricing of $30 Million Public Offering o... | BASEL, Switzerland, June 14, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VE... | globenewsw... |
05.04.2022 | VectivBio signs a $117m Japan exclusive license deal and loa... |
Based in Basel, VectivBio is a clinical-stage biopharmaceutical company pioneering novel transform... | startuptic... |
30.03.2022 | Luca Santarelli's VectivBio bags $100M-plus in new funding f... | Luca Santarelli’s rare disease player VectivBio, just three years out from being founded by the Roch... | endpts.com... |
21.09.2021 | VectivBio : R&D Day presentation | VectivBio R&D Day
September 21, 2021
CONFIDENTIAL
Disclaimer and Forward-Looking Statements
... | marketscre... |
06.09.2021 | VectivBio expands drug pipeline | VectivBio (Nasdaq: VECT) is a global, clinical-stage biotechnology company focused on discovering, d... | startuptic... |
31.08.2021 | VectivBio : to Acquire Comet Therapeutics and Host R&D D... | - Acquisition of Innovative Small Molecule Platform Significantly Expands Rare Disease Pipeline -
- ... | marketscre... |
31.08.2021 | VectivBio : Acquisition of Innovative Small Molecule Platfor... | - Acquisition of Innovative Small Molecule Platform Significantly Expands Rare Disease Pipeline -
-... | marketscre... |
14.04.2021 | VECTIVBIO HOLDING AG
CORRECTION – VectivBio Announces Closi... | BASEL, Switzerland, April 13, 2021 (GLOBE NEWSWIRE) -- In a press release issued under the same head... | marketscre... |
14.04.2021 | VECTIVBIO HOLDING AG
VectivBio Announces Closing of $146.6 ... | BASEL, Switzerland, April 13, 2021 (GLOBE NEWSWIRE) -- VectivBio Holding AG, (“Vectiv” or “VectivBio... | marketscre... |
12.04.2021 | VectivBio with strong debut on Nasdaq |
Although VectivBio was founded only In 2019, the company has already one product candidate in Phas... | startuptic... |
12.04.2021 | VectivBio with strong debut on Nasdaq | Although VectivBio was founded only In 2019, the company has already one product candidate in Phase ... | startuptic... |
10.02.2021 | VectivBio Announces Start of Phase 3 Trial |
The phase 3 STARS (STudy of ApRaglutide in SBS) trial is a global clinical trial that represents t... | startuptic... |
10.02.2021 | VectivBio Announces Start of Phase 3 Trial | The phase 3 STARS (STudy of ApRaglutide in SBS) trial is a global clinical trial that represents the... | startuptic... |
03.02.2021 | VectivBio Announces First Patient Dosed in Pivotal Phase 3 T... |
BASEL, Switzerland, Feb. 3, 2021 /PRNewswire/ -- VectivBio Holding AG, a clinical-stage biotechnol... | prnewswire... |
30.12.2020 | New board members to accelerate growth |
Exnaton, an ETH spinoff providing a software platform (PowerQuartier) for energy communities, welc... | startuptic... |
30.12.2020 | New board members to accelerate growth | Exnaton, an ETH spinoff providing a software platform (PowerQuartier) for energy communities, welcom... | startuptic... |
19.10.2020 | VectivBio Closes $110M Crossover Financing | VectivBio AG, a Basel, Switzerland-based clinical-stage biotechnology company developing transformat... | finsmes.co... |
19.10.2020 | VectivBio secures $110 million to finance Phase III clinical... |
VectivBio closed a $110 million crossover financing from new investors Surveyor Capital (a Citadel... | startuptic... |
19.10.2020 | VectivBio secures $110 million to finance Phase III clinical... | VectivBio closed a $110 million crossover financing from new investors Surveyor Capital (a Citadel c... | startuptic... |
15.10.2020 | VectivBio Closes $110 Million Crossover Financing to Advance... | - | orbimed.co... |
15.10.2020 | VectivBio Closes $110 Million Crossover Financing to Advance... |
BASEL, Switzerland, Oct. 15, 2020 /PRNewswire/ -- VectivBio AG, a clinical-stage biotechnology com... | prnewswire... |
09.01.2020 | Therachon spin-off launches with $35 million investment |
VectivBio, a clinical-stage biotechnology company, is bringing transformational medicines to patie... | startuptic... |
09.01.2020 | Therachon spin-off launches with $35 million investment | VectivBio, a clinical-stage biotechnology company, is bringing transformational medicines to patient... | startuptic... |
07.01.2020 | VectivBio Launches with $35M Financing to Bring Best-in-Dise... | - | orbimed.co... |
- | VectivBio Announces Pricing of $125 Million Underwritten Off... | - | tcgcrossov... |